Oxidative stress occurs when the body’s production of reactive oxygen species (ROS) outpaces its ability to neutralize them. Over time, this imbalance damages proteins, lipids, and DNA, contributing to aging and a range of chronic conditions. Researchers have been investigating whether naturally derived compounds can help tip this balance back toward cellular resilience.
Urolithin A is a compound produced in the gut when bacteria metabolize ellagitannins — polyphenols found in foods like pomegranates, walnuts, and certain berries. Because gut microbiome composition varies considerably between individuals, not everyone produces urolithin A efficiently from food alone. This has driven interest in urolithin A as a supplement, with a growing body of laboratory and clinical research examining its effects on oxidative stress.
Key Takeaways
- Urolithin A activates the Nrf2 pathway, a master regulator of the body’s own antioxidant defenses, across multiple tissue types including heart, skin, and brain cells.
- By promoting mitophagy — the clearance of damaged mitochondria — urolithin A may reduce one of the body’s primary internal sources of reactive oxygen species.
- Laboratory studies have found antioxidant effects in neuronal, cardiac, skin, immune, and reproductive cells, though most of this evidence comes from cell or animal models rather than human trials.
- A randomized human trial showed improvements in mitochondrial health biomarkers and physical performance, providing indirect support for urolithin A’s mitochondria-related antioxidant activity.
- Not everyone produces urolithin A efficiently from food; individual gut microbiome differences mean supplemental forms have been the focus of most controlled research.
Why Mitochondria Are Central to This Story
Mitochondria are the primary site of cellular energy production, but they are also a major source of ROS as a byproduct of that process. Damaged or dysfunctional mitochondria generate disproportionately high levels of ROS, creating a self-reinforcing cycle of oxidative damage. This is why mitochondrial quality control is considered a key lever in managing oxidative stress.
Mitophagy is the process by which cells identify and selectively degrade damaged mitochondria, clearing them before they become a net source of harm. Urolithin A is best known in research circles as a mitophagy inducer — it activates the cellular machinery responsible for this cleanup process. By reducing the burden of dysfunctional mitochondria, it may indirectly reduce one of the body’s main internal sources of ROS. Research in middle-aged adults found that urolithin A supplementation improved biomarkers of mitochondrial health alongside muscle strength and exercise performance [3], suggesting this mechanism operates in humans and not just cell culture.
The Nrf2 Pathway: A Key Mechanism
One of the most consistently reported mechanisms in urolithin A research is activation of the Nrf2 (nuclear factor erythroid 2-related factor 2) pathway. Nrf2 acts as a master regulator of the body’s endogenous antioxidant defenses. When activated, it moves into the cell nucleus and switches on genes that produce protective enzymes such as heme oxygenase-1, glutathione peroxidase, and superoxide dismutase — proteins that directly neutralize ROS and repair oxidative damage.
Several studies in the provided evidence specifically identify Nrf2 activation as the mechanism behind urolithin A’s antioxidant effects. In a cardiac model, urolithin A attenuated oxidative stress and a form of iron-dependent cell death called ferroptosis by working through the Nrf2 pathway [8]. Similarly, urolithin A protected human dermal fibroblasts from ultraviolet A-induced photoaging through NRF2 activation alongside mitophagy [2]. A urolithin A derivative (UAS03) designed for brain penetration also relied on Nrf2 pathway activation to reduce oxidative stress and neuroinflammation in a cognitive impairment model [9]. The consistent appearance of Nrf2 across these different tissue types suggests it may be a primary — though not the only — mechanism involved.
Oxidative Stress in the Brain: Early Findings
The brain is particularly vulnerable to oxidative damage because of its high metabolic rate and relatively modest antioxidant capacity compared to other tissues. Neurodegenerative diseases are closely associated with mitochondrial dysfunction and chronic oxidative stress in neurons.
Laboratory work in neuronal Neuro-2a cells found that urolithin A ameliorated artificially induced oxidative stress, positioning it as a potential neuroprotective agent [1]. A separate study found partial protection against oxidative damage caused by microcystin-LR — a toxin that generates oxidative injury — in C6 glial cells [4]. These are cell-based findings, meaning they establish plausibility rather than confirming effects in the human brain. The urolithin A derivative study mentioned above represents a step toward more complex brain models, but direct human neurological data remain limited [9].
ROS, Inflammation, and the Immune Connection
Oxidative stress and inflammation are tightly interlinked. ROS can directly activate the NLRP3 inflammasome — a protein complex that drives the production of potent inflammatory signals. Urolithin A has been shown to suppress NLRP3 inflammasome activation specifically by inhibiting ROS generation, and this effect was demonstrated in a model of gout-like inflammation caused by urate crystals [6]. This places urolithin A at a functional intersection between antioxidant activity and anti-inflammatory signaling.
Oxidative stress also plays a role in acute lung injury during serious illness. In a model of sepsis-induced lung injury, urolithin A supplementation reduced mitochondrial dysfunction and ROS-associated damage, in part by shifting macrophage polarization away from inflammatory states [11]. These findings are from animal or in vitro models, so caution is warranted before drawing conclusions about human disease, but they help illustrate the range of physiological contexts where urolithin A’s antioxidant mechanisms have been studied.
Skin, Reproductive Cells, and Other Emerging Areas
Beyond muscle and brain, researchers have examined urolithin A’s effects on oxidative stress in more specialized contexts. Ultraviolet radiation is a direct cause of ROS generation in skin cells, contributing to photoaging and DNA damage. A study found that urolithin A protected human dermal fibroblasts from UVA-induced oxidative stress through both NRF2 activation and the induction of mitophagy, suggesting a dual protective mechanism in skin [2].
Reproductive biology is another emerging area. Laboratory work using porcine oocytes — often used as a model for studying human egg cell biology — found that urolithin A protected against artificially induced oxidative stress, improving oocyte maturation rates and subsequent embryo development outcomes [10]. It is important to note these are animal laboratory models, and extrapolation to human fertility requires considerable caution and further research.
There is also evidence that urolithin A affects immune cell function through pathways that intersect with oxidative stress. One study found it improved the fitness of CD8+ T cells — key players in anti-tumor immunity — through a mechanism involving the ERK1/2-ULK1 signaling cascade [5]. How this connects to oxidative stress management in immune cells is an area of ongoing investigation.
What Human Evidence Exists?
Most of the oxidative stress research on urolithin A has been conducted in cell lines or animal models. The strongest human data to date comes from a randomized clinical trial in middle-aged adults, which found that urolithin A supplementation improved muscle strength, exercise performance, and biomarkers associated with mitochondrial health — a closely related outcome — compared to placebo [3]. This trial did not measure oxidative stress markers directly as primary endpoints, but mitochondrial health and ROS production are functionally linked.
Researchers have also noted that urolithin A’s production from dietary sources varies widely between individuals depending on gut microbiome composition [7]. This means that studies using supplemental urolithin A may produce different results than dietary interventions, and that blood levels from the same food intake can differ substantially between people. Standardized supplementation helps control for this variability in research settings.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day — The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10) — established clinical-supplement brand, third-party tested. - ProHealth Longevity Urolithin A
capsules, 500 mg — Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg — Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The majority of evidence for urolithin A and oxidative stress comes from cell culture and animal studies, which do not always translate to effects in humans; the single large randomized trial measured mitochondrial health markers rather than oxidative stress directly. Urolithin A supplements are not intended to diagnose, treat, or prevent any disease, and anyone with an existing health condition — particularly cardiac, neurological, or immune-related — should consult a qualified healthcare provider before use.
Frequently Asked Questions
How does urolithin A reduce oxidative stress at the cellular level?
The two primary mechanisms identified in research are Nrf2 pathway activation and mitophagy induction. Nrf2 activation switches on genes that produce antioxidant enzymes, while mitophagy removes damaged mitochondria that generate excess ROS. Both pathways have been observed in studies across cardiac, skin, and neural cell models [8] [2].
Has urolithin A been tested for oxidative stress effects in humans?
Direct measurement of oxidative stress markers was not a primary endpoint in the largest human trial to date, but that randomized trial in middle-aged adults did find improvements in mitochondrial health biomarkers alongside muscle and exercise outcomes [3]. Human data specifically measuring oxidative stress responses remain limited.
What is ferroptosis, and how does urolithin A relate to it?
Ferroptosis is a form of cell death driven by iron-dependent lipid oxidation — essentially a specific type of oxidative damage. Research found that urolithin A reduced ferroptosis in a model of cardiac ischemia-reperfusion injury, working through the Nrf2 antioxidant pathway [8]. This is an active research area and findings are preliminary.
Can urolithin A help with skin aging caused by sun exposure?
A laboratory study found that urolithin A protected human dermal fibroblasts from UVA-induced oxidative damage through NRF2 activation and mitophagy [2]. These are cell-based findings and do not constitute clinical evidence for topical or oral use in humans for photoaging.
Does urolithin A have anti-inflammatory effects connected to its antioxidant activity?
Yes, the two appear to be linked. Urolithin A was found to suppress NLRP3 inflammasome activation — a key driver of inflammatory signaling — specifically by inhibiting ROS generation [6]. Since oxidative stress can trigger inflammation, reducing ROS may be one way urolithin A exerts anti-inflammatory effects.
Why do some people produce more urolithin A than others from their diet?
Urolithin A is produced when gut bacteria metabolize ellagitannins from foods like pomegranates and walnuts. Because gut microbiome composition varies considerably between individuals, some people are efficient urolithin A producers and others produce very little regardless of dietary intake [7]. This biological variability is one reason researchers have focused on standardized supplemental forms.
References
- Cásedas G et al. The Metabolite Urolithin-A Ameliorates Oxidative Stress in Neuro-2a Cells, Becoming a Potential Neuroprotective Agent. Antioxidants (Basel, Switzerland) (2020). PMID 32098107
- Liu W et al. Urolithin A protects human dermal fibroblasts from UVA-induced photoaging through NRF2 activation and mitophagy. Journal of photochemistry and photobiology. B, Biology (2022). PMID 35567884
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Von Sulzback Brasil A et al. Urolithin a Partially Protects against Oxidative Damage Induced for Microcistyn-lr in C6 Cells. Chemistry & biodiversity (2024). PMID 38385951
- Ma S et al. Urolithin A Hijacks ERK1/2-ULK1 Cascade to Improve CD8(+) T Cell Fitness for Antitumor Immunity. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2024). PMID 38447147
- Komatsu W et al. Urolithin A suppresses NLRP3 inflammasome activation by inhibiting the generation of reactive oxygen species and prevents monosodium urate crystal-induced peritonitis. Bioscience, biotechnology, and biochemistry (2024). PMID 38772744
- Broome SC et al. Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. Sports medicine (Auckland, N.Z.) (2024). PMID 39060742
- Su Z et al. Urolithin A improves myocardial ischemia-reperfusion injury by attenuating oxidative stress and ferroptosis through Nrf2 pathway. International immunopharmacology (2024). PMID 39437484
- Maity D et al. Urolithin-A Derivative UAS03 Improves Cognitive Deficits and Memory by Activating Nrf2 Pathways to Alleviate Oxidative Stress and Neuroinflammation. ACS chemical neuroscience (2025). PMID 40227891
- Shi W et al. Urolithin A Protects Porcine Oocytes from Artificially Induced Oxidative Stress Damage to Enhance Oocyte Maturation and Subsequent Embryo Development. International journal of molecular sciences (2025). PMID 40243704
- Mohsin M et al. Urolithin-A supplementation alleviates sepsis-induced acute lung injury by reducing mitochondrial dysfunction and modulating macrophage polarization. Mitochondrion (2025). PMID 40328344
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
